Page last updated: 2024-08-17

levodopa and MPTP Neurotoxicity Syndrome

levodopa has been researched along with MPTP Neurotoxicity Syndrome in 151 studies

Research

Studies (151)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.66)	18.7374
1990's	30 (19.87)	18.2507
2000's	46 (30.46)	29.6817
2010's	70 (46.36)	24.3611
2020's	4 (2.65)	2.80

Authors

Authors	Studies
Bui, BV; Finkelstein, DI; Hoang, A; Lim, JKH; Nguyen, CTO; Shahandeh, A; Tran, KKN; Wong, VHY	1
Beaudry, F; Bédard, D; Gaudette, F; Gourdon, JC; Hamadjida, A; Huot, P; Michaud, V; Nuara, SG; Panisset, M; Sid-Otmane, L	1
Andren, PE; Bezard, E; Crossman, AR; Fridjonsdottir, E; Hulme, H; Li, Q; Nilsson, A; Pioli, E	1
Asakawa, T; Kobayashi, S; Kurozumi, K; Nozaki, T; Sameshima, T; Sugiyama, K	1
Pandey, S; Singh, B; Yadav, SK	1
Gourdon, JC; Hamadjida, A; Huot, P; Nuara, SG	2
Bourque, M; Di Paolo, T; Grégoire, L	1
Feher, M; Fernandez-Villalba, E; Gaszner, B; Gil-Martinez, AL; Herrero, MT; Reglodi, D; Tamas, A	1
Beck, G; Chang, PL; Maehara, S; Papa, SM	1
Baufreton, J; Bessière, B; Bezard, E; Chazalon, M; Courtine, G; Farjot, G; Ko, WKD; Li, Q; McGuire, S; Milekovic, T; Milet, A; Moraud, EM; Morin, S; Normand, E; Pioli, E; Porras, G; Pype, J; Sun, S	1
Beaudoin-Gobert, M; Duperrier, S; Météreau, E; Sgambato, V; Thobois, S; Tremblay, L	1
Che, Y; Feng, X; Jiang, P; Lang, Q; Liu, Q; Tang, X; Yu, Q; Zhang, S; Zhu, D	1
Iggena, D; Klein, C; Rasińska, J; Sparenberg, M; Steiner, B; Winter, Y	1
Brotchie, JM; Fox, SH; Graef, JD; Hill, MP; Huot, P; James, JW; Johnston, TH; Jordan, KG; Koprich, JB; Letchworth, SR; Szeliga, KT	1
Ly, J; Mallela, A; Quik, M; Zhang, D	1
Chakraborty, J; Dhanasekaran, M; Manivasagam, T; Mohanakumar, KP; Naskar, A; Singh, R; Thomas, B	1
Bagga, P; Chugani, AN; Patel, AB; Varadarajan, KS	1
Jackson, MJ; Jenner, P; Pearce, RK; Swart, T	1
Hurley, MJ; Jackson, MJ; Jenner, P; Rose, S; Smith, LA	1
Bordia, T; Decker, MW; McGregor, M; McIntosh, JM; Quik, M; Zhang, D	1
Bezard, E; Dufour, A; Facheris, MF; Ko, WK; Li, Q; McGuire, S; Pioli, E; Sherer, TB	1
Georgieva, SG; Kerkerian-Le Goff, L; Khaindrava, VG; Khakimova, GR; Kozina, EA; Krasnov, AN; Kucheryanu, VG; Ugrumov, MV; Vorobyeva, NE	1
Bliwise, D; Devergnas, A; Pittard, D; Wichmann, T	1
Bezard, E; De Deurwaerdère, P; Engeln, M; Fernagut, PO; Li, Q	1
Bezard, E; Girard, F; Keywood, C; Li, Q; Mutel, V; Pioli, EY; Poli, SM; Rascol, O; Tison, F	1
Adrien, J; Arnulf, I; Belaid, H; Clark, SD; Drouot, X; François, C; Grabli, D; Hirsch, EC; Karachi, C; Laffrat, E; Tandé, D	1
Decker, MW; McGregor, M; Quik, M; Zhang, D	1
Di Paolo, T; Elbast, W; Feuerbach, D; Gomez-Mancilla, B; Grégoire, L; Weiss, M	1
Di Paolo, T; Grégoire, L; Jourdain, VA; Morin, N; Morissette, M	1
Cao, X; Kaneoke, Y; Liang, L; Papa, SM; Singh, A	1
Brotchie, JM; Fox, SH; Huot, P; Johnston, TH	1
Ji, C; Liu, Y; Ren, Z; Wang, T; Yang, N; Zheng, J; Zuo, P	1
Bezard, E; Carta, M; Chuan, Q; Fidalgo, C; Ko, WK; Li, Q; Stancampiano, R; Tronci, E	1
Brotchie, JM; Fox, SH; Huot, P; Johnston, TH; Newman-Tancredi, A	1
Ballanger, B; Bars, DL; Beaudoin-Gobert, M; Bonnefoi, F; Broussolle, E; Costes, N; Duperrier, S; Epinat, J; Lavenne, F; Liger, F; Météreau, E; Neumane, S; Sgambato-Faure, V; Thobois, S; Tourvielle, C; Tremblay, L	1
Andersen, JK; Kim, YH; Lazzara, CA; Rane, A; Riley, RR	1
Di Paolo, T; Grégoire, L; Morin, N; Morissette, M; Rajput, A; Rajput, AH	1
Jenner, P; Kanda, T; Kawai-Uchida, M; Mori, A; Okita, E; Soshiroda, K; Uchida, S	1
Kim, AR; Ugryumov, MV	1
Harada, N; Kakiuchi, T; Kanazawa, M; Muramatsu, S; Ohba, H; Tsukada, H	1
Bernstein, AI; Chen, M; Dunn, AR; Hoffman, CA; Lohr, KM; McDaniel, MJ; Miller, GW; Stout, KA; Wang, M	1
Chu, Y; Isacson, O; Kordower, JH; Redmond, DE; Vinuela, A	1
Bezard, E; Camus, SM; Ko, WKD; Li, Q; McGuire, S; Pioli, EY; Yang, J	1
Daniels, JS; Devergnas, A; Galvan, A; Lindsley, CW; Masilamoni, G; Morrison, RD; Pittard, D; Vuong, J; Wichmann, T	1
Chan, P; Tang, R; Tao, G; Yue, F; Zeng, S	1
Frouni, I; Gourdon, JC; Hamadjida, A; Harraka, MJ; Huot, P; Kwan, C; Nuara, SG; Sid-Otmane, L; Veyres, N	1
Betz, AJ; Bibbiani, F; Chase, TN; Davis, RE; Kielaite, A; Salamone, JD; Vanover, KE; Weber, SM; Weiner, DM	1
Desole, MS; Marchetti, B; Miele, E; Pluchino, S; Serra, PA	1
Buck, K; Ferger, B; Nicholas, AP	1
Belkhir, S; Di Paolo, T; Dridi, M; Grégoire, L; Meltzer, LT; Morissette, M; Ouattara, B; Samadi, P	1
Brotchie, JM; de Bie, RM; Fox, SH; Johnston, TH; McCreary, AC; Visanji, NP	1
Brennum, LT; Kirchhoff, J; Mørk, A; Sager, TN	1
Decamp, E; Schneider, JS	1
Aubert, I; Berton, O; Bezard, E; Bioulac, BH; Dileone, RJ; Gross, CE; Guigoni, C; Li, Q; Nestler, EJ	1
Iravani, MM; Jackson, MJ; Jenner, P; Olanow, CW; Rose, S; Scheller, D; Smith, LA; Stockwell, KA; Tayarani-Binazir, K	1
Di Paolo, T; Gilbert, F; Grégoire, L; Lévesque, D; Mahmoudi, S; Morissette, M; Ouattara, B; Rouillard, C; Samadi, P	1
Balfour, RH; Jackson, MJ; Jenner, P; Rose, S; Zeng, BY	1
Andree, TH; Hansard, M; Hoffman, DC; Hurtt, MR; Jackson, MJ; Jenner, P; Kehne, JH; Pitler, TA; Smith, LA; Stack, G	1
Iravani, MM; Jackson, MJ; Jenner, P; Rose, S; Scheller, DK; Smith, LA; Stockwell, KA	1
Borah, A; Mohanakumar, KP	1
Di Paolo, T; Lévesque, D; Morissette, M; Samadi, P	1
Jackson, MJ; Jenner, P; Olanow, CW; Rose, S; Tayarani-Binazir, KA	1
Di Paolo, T; Gasparini, F; Gomez-Mancilla, B; Grégoire, L; Morissette, M; Ouattara, B; Samadi, P	1
Brotchie, JM; Fox, SH; Johnston, TH; McIldowie, MJ; Piggott, MJ	1
Di Paolo, T; Gasparini, F; Gomez-Mancilla, B; Grégoire, L; Hoyer, D; Morissette, M; Ouattara, B	1
Brotchie, JM; Fox, SH; Johnston, TH; van der Meij, A	1
Brotchie, JM; Fox, SH; Huot, P; Johnston, TH; Winkelmolen, L	1
Brotchie, JM; Fox, SH	1
Bartolini, WP; Brotchie, JM; Fox, SH; Huot, P; Johnston, TH; Milne, GT; Pearson, JP; Sykes, KA; Wakefield, JD	1
Bakay, RA; Deogaonkar, M; Lieu, CA; Subramanian, T	1
Hansard, MJ; Jackson, MJ; Jenner, P; Rose, S; Smith, LA	1
Brotchie, JM; Fox, SH; Huot, P; Johnston, TH; Koprich, JB; Lewis, KD; Piggott, MJ; Reyes, MG	1
Brotchie, JM; Visanji, NP	1
Crossman, AR; Hill, MP; Kobylecki, C; Ravenscroft, P	1
Iwamuro, H; Kita, H; Nambu, A; Tachibana, Y; Takada, M	1
Liang, L; Pu, X; Wang, J; Wang, X; Wu, Q; Xiang, Y; Zhang, Q; Zhang, X	1
Campos-Romo, A; Carrillo-Ruiz, JD; Fernandez-Ruiz, J; Moreno-Briseño, P; Ojeda-Flores, R; Segovia, J; Vergara, P	1
Bordia, T; Chin, M; Mallela, A; McIntosh, JM; Perez, XA; Quik, M	1
Bankiewicz, KS; Cummins, A; Eberling, J; Kohutnicka, M; Oiwa, Y; Sanchez-Pernaute, R	2
Di Paolo, T; Grégoire, L; Jourdain, VA; Morin, N; Morissette, M; Parent, M	1
Hermann, A; Huehnchen, P; Klaissle, P; Lesemann, A; Steiner, B; Storch, A	1
Bezard, E; Jianzhong, Y; Li, Q; Pioli, EY; Schneider, JS	1
Brotchie, JM; Fox, SH; Hill, MP; Huot, P; Johnston, TH; Koprich, JB; Snoeren, T	1
Brotchie, JM; Fox, SH; Huot, P; Jarvie, K; Koprich, JB; Lang, AE; Seeman, P	1
Dunnett, SB; Lane, EL; Lelos, MJ	1
Archer, T; Fredriksson, A	4
Bankiewicz, KS; Emborg, ME; McLaughlin, WW; Moirano, J; Tetrud, JW	1
Bézard, E; Boraud, T; Ferry, S; Gross, C; Leriche, L; Mach, U; Sokoloff, P; Stark, H	1
Bordia, T; Fan, H; Marks, MJ; McIntosh, JM; Okihara, M; Quik, M; Whiteaker, P	1
Antkiewicz-Michaluk, L; Herman, ZS; Obuchowicz, E; Romańska, I	1
Bezard, E; Brotchie, JM; Crossman, AR; Grimée, R; Hill, MP; Klitgaard, H; Michel, A	1
Brocco, M; Brotchie, J; Crossman, A; Di Cara, B; Gobert, A; Hill, M; Jackson, M; Jenner, P; Joyce, JN; McGuire, S; Millan, MJ; Peglion, JL; Smith, L	1
Bezard, E; Brotchie, JM; Crossman, AR; Grimée, R; Hill, MP; Klitgaard, H; Michel, A; Ravenscroft, P	1
Aubin, N; Barneoud, P; Burnier, P; Caille, D; Carter, C; Charieras, T; Curet, O; Gardes, A; George, P; Jegham, S; Le Kim, A; Lolivier, J; Marc, C; Pandini, M; Perron, C; Puech, F; Scatton, B; Sontag, N	1
Al-Barghouthy, G; Jackson, MJ; Jenner, P; Kuoppamaki, M; Olanow, W; Rose, S; Smith, LA	1
Brotchie, JM; Crossman, AR; Nicholson, SL; Silverdale, MA	1
Alvarez, L; Castro, A; Gimenez-Roldan, S; Grandas, F; Hernandez, B; Jenner, P; Linazasoro, G; Luquin, MR; Macias, R; Marin, C; Obeso, JA; Pavon, N; Rodriguez, M; Rodriguez-Oroz, MC; Stochi, F; Tolosa, E; Vaamonde, J; Valldeoriola, F	1
Brotchie, JM; Crossman, AR; Di Marzo, V; Fox, SH; Hill, M; Petrosino, S; van der Stelt, M	1
Childs, MA; Connell, MA; Emborg, ME; Hajos-Korcsok, E; Meglasson, MD; Stephenson, DT	1
Diguet, E; Fernagut, PO; Ghorayeb, I; Tison, F	1
Bankiewicz, KS; Bringas, J; Cunningham, J; Daadi, M; Eberling, JL; Forsayeth, JR; Pivirotto, P; Sanftner, L	1
Bédard, PJ; Di Paolo, T; Grégoire, L; Lévesque, D; Rouillard, C; Samadi, P	1
Aziz, TZ; Jenkinson, N; Nandi, D; Oram, R; Stein, JF	1
Carminati, P; Jackson, MJ; Jenner, P; Johnson, L; Rose, S; Smith, LA; Stockwell, K	1
Brotchie, JM; Crossman, AR; Hill, MP; McGuire, SG; Millan, MJ; Ravenscroft, P; Rochat, C	1
Caccia, C; Calabresi, M; Curatolo, L; Faravelli, L; Fariello, RG; Maestroni, S; Maj, R; Salvati, P	1
Chalimoniuk, M; Langfort, J	1
Al-Barghouthy, G; Jackson, MJ; Jenner, P; Kuoppamäki, M; Quinn, N; Smith, LA	1
Hurley, MJ; Jackson, MJ; Jenner, P; Patel, PH; Rose, S; Smith, LA	1
Dunnett, S; Lane, E	1
Crossman, AR; Page, RD; Sambrook, MA	1
Fukuda, T; Irifune, M; Nomoto, M	1
Bédard, PJ; Blanchet, P; Britton, DR; Kebabian, JW	1
Crossman, AR; Graham, WC; Sambrook, MA	1
Dluzen, D; Jain, R; Liu, B	1
Agid, Y; Augood, SJ; Emson, PC; Herrero, MT; Hirsch, EC; Javoy-Agid, F; Luquin, MR; Obeso, JA	1
Dluzen, DE; Liu, B; McDermott, JL	1
Agid, Y; Faucheux, B; Herrero, MT; Hirsch, EC; Levy, R; Obeso, JA; Vila, M	1
Agid, Y; Asensi, H; Augood, SJ; Emson, PC; Herrero, MT; Hirsch, EC; Obeso, JA	1
Agid, Y; Faucheux, B; Herrero, MT; Hirsch, EC; Levy, R; Obeso, JA; Ruberg, M; Vila, M	1
Iurasov, VV; Kaplun, AP; Kryzhanovskiĭ, GN; Kucherianu, VG; Kudrin, VS; Nikushkin, EV; Podgornyĭ, GI; Sandalov, IuG; Shvets, VI; Zhigal'tsev, IV	1
Blanchet, PJ; Chase, TN; Konitsiotis, S	1
Bezard, E; Bioulac, B; Boraud, T; Gross, C; Guehl, D	1
Domino, EF; Emborg-Knott, ME	1
Domino, EF; Ni, L	1
Blanchet, PJ; Chase, TN; Konitsiotis, S; Whittemore, ER; Woodward, RM; Zhou, ZL	1
Andringa, G; Cools, AR; Stoof, JC	1
Aigner, TG; Doudet, D; Fernández-Ruiz, J	1
Bédard, PJ; Doan, VD; Grondin, R; Hadj Tahar, A; Ladure, P	1
Bezard, E; Boraud, T; Gross, CE; Guitraud, S; Imbert, C	1
Jenner, P	1
Andringa, G; Cools, AR; Drukarch, B; Lubbers, L; Stoof, JC	1
Fukuzaki, K; Kamenosono, T; Kitazumi, K; Nagata, R	1
Cannizzaro, C; Costa, S; Iravani, MM; Jackson, MJ; Jenner, P; Pearce, RK; Tel, BC	1
Foster, AC; Hill, RG; Iversen, L; Iversen, SD; Kemp, JA; Leeson, PD; Rupniak, NM; Saywell, K; Tricklebank, MD; Williams, BJ	1
Marsden, CD	1
Bédard, PJ; Blanchette, P; Di Paolo, T; Gagnon, C; Mancilla, BG	1
Lieberman, A	1
Gash, DM; Greenamyre, JT; Honoré, T; Klockgether, T; Kurlan, R; Turski, L; Zhang, ZM	1
Bédard, PJ; Gomez-Mancilla, B	1
Asanuma, M; Haba, K; Mori, A; Ogawa, N; Pongdhana, K; Sora, YH	1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, S	1
Bodis-Wollner, I; Chung, E; Ghilardi, MF; Glover, A; Onofrj, M; Pasik, P; Samson, Y	1
Bédard, PJ; Di Paolo, T; Rouillard, C	1
Boyce, S; Clarke, CE; Crossman, AR; Luquin, R; Mitchell, IJ; Peggs, D; Robertson, RG; Sambrook, MA	1
Boyce, S; Crossman, AR; Luquin, MR; Peggs, D; Sambrook, MA	1

Reviews

9 review(s) available for levodopa and MPTP Neurotoxicity Syndrome

Article	Year
The MPTP mouse model: cues on DA release and neural stem cell restorative role. Parkinsonism & related disorders, 2008, Volume: 14 Suppl 2 Topics: Animals; Antiparkinson Agents; Corpus Striatum; Cues; Disease Models, Animal; Dopamine; Humans; Levodopa; Mice; MPTP Poisoning; Stem Cell Transplantation; Stem Cells	2008
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. Progress in brain research, 2010, Volume: 184 Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Basal Ganglia; Cognition Disorders; Disease Models, Animal; Dopamine; Drug Discovery; Endpoint Determination; Humans; Levodopa; Movement; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Primates; Psychoses, Substance-Induced; Sleep Wake Disorders	2010
[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination]. Neurologia (Barcelona, Spain), 2005, Volume: 20, Issue:4 Topics: Akathisia, Drug-Induced; Animals; Antiparkinson Agents; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine; Drug Therapy, Combination; Humans; Hyperhomocysteinemia; Levodopa; MPTP Poisoning; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Rats; Treatment Outcome	2005
Safinamide: from molecular targets to a new anti-Parkinson drug. Neurology, 2006, Oct-10, Volume: 67, Issue:7 Suppl 2 Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Brain Ischemia; Disease Models, Animal; Gerbillinae; Humans; Kainic Acid; Levodopa; Mice; MPTP Poisoning; Neurons; Rats; Veratridine	2006
Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic? Psychopharmacology, 2008, Volume: 199, Issue:3 Topics: Animals; Animals, Genetically Modified; Antiparkinson Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Humans; Levodopa; MPTP Poisoning; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Reproducibility of Results; Sympatholytics	2008
Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates. Annals of neurology, 2000, Volume: 47, Issue:4 Suppl 1 Topics: Animals; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; MPTP Poisoning; Primates	2000
Neurotoxin-related research: from the laboratory to the clinic. Annals of the New York Academy of Sciences, 1992, May-11, Volume: 648 Topics: Animals; Antiparkinson Agents; Dopamine Agents; Humans; Levodopa; Mice; MPTP Poisoning; Nervous System; Neurotoxins; Oxazines; Parkinson Disease, Secondary; Prodrugs; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Saimiri	1992
Parkinson's disease. Postgraduate medical journal, 1992, Volume: 68, Issue:801 Topics: Dopamine; Environmental Pollutants; Humans; Levodopa; MPTP Poisoning; Parkinson Disease	1992
Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us? The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1992, Volume: 19, Issue:1 Suppl Topics: Animals; Disease Models, Animal; Dyskinesia, Drug-Induced; Haplorhini; Humans; Levodopa; MPTP Poisoning	1992

Other Studies

142 other study(ies) available for levodopa and MPTP Neurotoxicity Syndrome

Article	Year
Characterization of retinal function and structure in the MPTP murine model of Parkinson's disease. Scientific reports, 2022, 05-09, Volume: 12, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Levodopa; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease; Retina; Tyrosine 3-Monooxygenase	2022
Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset. European journal of pharmacology, 2020, Apr-15, Volume: 873 Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Female; GABA Modulators; Levodopa; Male; MPTP Poisoning; Parkinson Disease; Psychoses, Substance-Induced; Pyridines; Receptors, Metabotropic Glutamate; Sulfonamides	2020
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020, 08-26, Volume: 40, Issue:35 Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Dyskinesias; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Humans; Levodopa; Macaca fascicularis; MPTP Poisoning; Neurotransmitter Agents; Receptors, Opioid, mu	2020
Development of a novel gripping test for the evaluation of the finger fine motor ability in MPTP-treated monkeys. Journal of integrative neuroscience, 2020, Jun-30, Volume: 19, Issue:2 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Deep Brain Stimulation; Disease Models, Animal; Fingers; Levodopa; Macaca fascicularis; Male; Motor Activity; Motor Skills; MPTP Poisoning; Neuropsychological Tests; Parkinson Disease; Reproducibility of Results; Subthalamic Nucleus	2020
Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study. Journal of chemical neuroanatomy, 2017, Volume: 85 Topics: Acetylcholinesterase; Animals; Cognition Disorders; Dopaminergic Neurons; Estradiol; Levodopa; Maze Learning; Mice; MPTP Poisoning; Neuroprotective Agents; Ovariectomy; Substantia Nigra; Tyrosine 3-Monooxygenase	2017
The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset. Progress in neuro-psychopharmacology & biological psychiatry, 2018, 02-02, Volume: 81 Topics: Animals; Antidepressive Agents, Second-Generation; Callithrix; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Mianserin; MPTP Poisoning; Psychotic Disorders; Severity of Illness Index; Time Factors; Treatment Outcome	2018
The plasmalogen precursor analog PPI-1011 reduces the development of L-DOPA-induced dyskinesias in de novo MPTP monkeys. Behavioural brain research, 2018, Jan-30, Volume: 337 Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; MPTP Poisoning; Ovariectomy; Plasmalogens; Time Factors	2018
Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys. Neurotoxicity research, 2018, Volume: 33, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; Basal Ganglia; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Phosphopyruvate Hydratase; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Tyrosine 3-Monooxygenase	2018
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2018, Volume: 125, Issue:9 Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Behavior, Animal; Callithrix; Disorders of Excessive Somnolence; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Parkinsonian Disorders; Serotonin Receptor Agonists; Trazodone	2018
A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:5 Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Organic Chemicals; Phosphodiesterase Inhibitors	2018
Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:10 Topics: Administration, Inhalation; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Green Fluorescent Proteins; Levodopa; Mice; Mice, Transgenic; MPTP Poisoning; Oxidopamine; Parkinsonian Disorders; Rats; Sensation Disorders; Sympatholytics; Time Factors; Xenon	2018
Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates. NeuroImage, 2018, Volume: 183 Topics: Animals; Brain; Diffusion Tensor Imaging; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Immunohistochemistry; Levodopa; Macaca fascicularis; MPTP Poisoning; Multimodal Imaging; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Fibers; Parkinson Disease, Secondary; Positron-Emission Tomography; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins	2018
Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice. Behavioural brain research, 2019, 07-23, Volume: 367 Topics: Animals; Antioxidants; Antiparkinson Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Levodopa; Mice; Mice, Inbred BALB C; MPTP Poisoning; Resveratrol	2019
Physical activity sustains memory retrieval in dopamine-depleted mice previously treated with L-Dopa. Behavioural brain research, 2019, 09-02, Volume: 369 Topics: Animals; Antiparkinson Agents; Benserazide; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Combinations; Female; Green Fluorescent Proteins; Hippocampus; Levodopa; Maze Learning; Memory; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; MPTP Poisoning; Neurogenesis; Random Allocation; Sedentary Behavior	2019
TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque. Neuropharmacology, 2013, Volume: 73 Topics: Amantadine; Animals; Azabicyclo Compounds; Cyclopropanes; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; MPTP Poisoning; Nicotinic Agonists	2013
Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:10 Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Cotinine; Data Interpretation, Statistical; Dyskinesia, Drug-Induced; Female; Levodopa; Male; MPTP Poisoning; Nicotine; Nicotinic Agonists; Parkinson Disease, Secondary; Saimiri	2013
Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism. Journal of pineal research, 2013, Volume: 55, Issue:3 Topics: Animals; Antiparkinson Agents; Central Nervous System Depressants; Corpus Striatum; Dendrites; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Melatonin; Mice; Mice, Inbred BALB C; MPTP Poisoning; Parkinson Disease, Secondary	2013
In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment. Journal of neurochemistry, 2013, Volume: 127, Issue:3 Topics: Acetates; Algorithms; Animals; Antiparkinson Agents; Blood Glucose; Brain Chemistry; Energy Metabolism; Glutamates; Hand Strength; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Oxidation-Reduction; Parkinson Disease, Secondary; Psychomotor Performance; Radiopharmaceuticals	2013
Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets. Journal of neural transmission (Vienna, Austria : 1996), 2014, Volume: 121, Issue:2 Topics: Animals; Antiparkinson Agents; Callithrix; Carbidopa; Cholinergic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Statistics, Nonparametric	2014
Proteomic analysis of striatum from MPTP-treated marmosets (Callithrix jacchus) with L-DOPA-induced dyskinesia of differing severity. Journal of molecular neuroscience : MN, 2014, Volume: 52, Issue:2 Topics: Animals; Callithrix; Dyskinesias; Levodopa; MPTP Poisoning; Neostriatum; Proteome	2014
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:4 Topics: Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Levodopa; Male; MPTP Poisoning; Nicotinic Agonists; Pyridines; Pyrrolidines; Saimiri; Treatment Outcome	2014
Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:6 Topics: Amantadine; Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Imidazoles; Levodopa; Macaca fascicularis; MPTP Poisoning	2014
Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism. Journal of the neurological sciences, 2014, May-15, Volume: 340, Issue:1-2 Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Electrochemistry; Gene Expression Regulation; Hydrazines; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase	2014
Relationship between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys. Neurobiology of disease, 2014, Volume: 68 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Basal Ganglia; Brain Waves; Disease Models, Animal; Electroencephalography; Fourier Analysis; Globus Pallidus; Levodopa; Macaca mulatta; Motor Activity; Motor Cortex; MPTP Poisoning; Neural Pathways; Physical Stimulation; Sleep; Subthalamic Nucleus; Time Factors; Wakefulness	2014
Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia. Cerebral cortex (New York, N.Y. : 1991), 2015, Volume: 25, Issue:9 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Biogenic Monoamines; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca mulatta; MPTP Poisoning; Neural Pathways; Time Factors	2015
The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:8 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Imidazoles; Levodopa; Macaca mulatta; Male; Motor Activity; MPTP Poisoning; Pyridines; Receptor, Metabotropic Glutamate 5; Severity of Illness Index; Time Factors	2014
Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Jul-02, Volume: 34, Issue:27 Topics: Animals; Benserazide; Cholinergic Neurons; Diphtheria Toxin; Drug Combinations; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Muscle Tonus; Parkinsonian Disorders; Pedunculopontine Tegmental Nucleus; Polysomnography; Recombinant Fusion Proteins; Sleep Deprivation; Sleep Disorders, Intrinsic; Sleep, REM; Urotensins; Wakefulness	2014
The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeys. The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:1 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; MPTP Poisoning; Nicotinic Agonists; Quinuclidines; Saimiri	2014
AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys. Parkinsonism & related disorders, 2014, Volume: 20, Issue:11 Topics: alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Nicotinic Agonists; Ovariectomy; Time Factors	2014
Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys. Experimental neurology, 2014, Volume: 261 Topics: Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Female; Levodopa; Macaca fascicularis; MPTP Poisoning; Ovariectomy; Protein Binding; Radioligand Assay; Receptors, Dopamine; Subthalamus	2014
Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates. Journal of neurophysiology, 2015, Mar-01, Volume: 113, Issue:5 Topics: Action Potentials; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Female; Levodopa; Macaca mulatta; MPTP Poisoning; Neurons; Receptors, Dopamine D2	2015
Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: results of a pilot study. Synapse (New York, N.Y.), 2015, Volume: 69, Issue:3 Topics: Animals; Antiparkinson Agents; Drug Combinations; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; MPTP Poisoning; Pilot Projects; Pioglitazone; Thiazolidinediones	2015
Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice. Neuropharmacology, 2015, Volume: 93 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Benzylidene Compounds; Cells, Cultured; Disease Models, Animal; Levodopa; Male; Membrane Potential, Mitochondrial; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; MPTP Poisoning; Neuroblastoma; Neurons; Neuroprotective Agents; Neurotoxins; Psychomotor Performance; rho GTP-Binding Proteins; Thiazolidinediones; Time Factors; Tyrosine 3-Monooxygenase	2015
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. Neuroscience, 2015, Jul-09, Volume: 298 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Citalopram; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tyrosine 3-Monooxygenase	2015
The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque. Neuropharmacology, 2015, Volume: 97 Topics: Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Piperidines; Pyrimidines; Serotonin 5-HT1 Receptor Agonists; Severity of Illness Index	2015
Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. Brain : a journal of neurology, 2015, Volume: 138, Issue:Pt 9 Topics: Aniline Compounds; Animals; Antiparkinson Agents; Brain; Brain Mapping; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Male; Mental Disorders; MPTP Poisoning; N-Methyl-3,4-methylenedioxyamphetamine; Nortropanes; Radionuclide Imaging; Serotonin; Serotonin Agents; Sulfides	2015
The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy. Brain research, 2015, Oct-05, Volume: 1622 Topics: Animals; Antiparkinson Agents; Brain Stem; Calpain; Carbidopa; Cell Death; Cell Line; Corpus Striatum; Dopaminergic Neurons; Drug Therapy, Combination; Histone Acetyltransferases; Levodopa; Lithium Chloride; Male; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Rats; Tyrosine 3-Monooxygenase	2015
Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. Neuropharmacology, 2015, Volume: 99 Topics: Aged; Aged, 80 and over; Animals; Antiparkinson Agents; Brain; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Humans; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Ovariectomy; Parkinson Disease; Pyridines; Receptor, Metabotropic Glutamate 5; Receptor, Serotonin, 5-HT1B	2015
The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets. European journal of pharmacology, 2015, Nov-05, Volume: 766 Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Dopamine Agonists; Drug Therapy, Combination; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Pergolide; Purines	2015
Changes in plasma catecholamines levels as preclinical biomarkers in experimental models of Parkinson's disease. Doklady. Biochemistry and biophysics, 2015, Volume: 464 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Disease Progression; Dopamine; Epinephrine; Levodopa; Male; Mice, Inbred C57BL; MPTP Poisoning; Norepinephrine; Prodromal Symptoms; Severity of Illness Index	2015
Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2 Topics: Animals; Brain; Carbidopa; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Presynaptic; Tyrosine	2016
Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals. Toxicological sciences : an official journal of the Society of Toxicology, 2016, Volume: 153, Issue:1 Topics: Animals; Corpus Striatum; Dopamine; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; MPTP Poisoning; Vesicular Monoamine Transport Proteins	2016
Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias. The Journal of comparative neurology, 2017, 02-15, Volume: 525, Issue:3 Topics: Animals; Antiparkinson Agents; Calbindins; Caudate Nucleus; Cerebellum; Chlorocebus aethiops; Dopamine; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Fetal Tissue Transplantation; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Levodopa; Male; Mesencephalon; Microglia; MPTP Poisoning; Neurons; Putamen; Tyrosine 3-Monooxygenase	2017
An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models. Neuropharmacology, 2016, Volume: 110, Issue:Pt A Topics: Adenosine A2 Receptor Antagonists; Animals; Cognition Disorders; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hypokinesia; Levodopa; Macaca fascicularis; Motor Skills Disorders; MPTP Poisoning; Purines; Treatment Outcome	2016
Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys. ACS chemical neuroscience, 2016, 11-16, Volume: 7, Issue:11 Topics: Animals; Antiparkinson Agents; Arousal; Azabicyclo Compounds; Benzamides; Brain; Calcium Channel Blockers; Calcium Channels, T-Type; Chromatography, Liquid; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Electrocorticography; Female; Heart; Levodopa; Macaca mulatta; Male; Mass Spectrometry; Motor Activity; MPTP Poisoning; Treatment Failure	2016
MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes. Neuroscience bulletin, 2017, Volume: 33, Issue:1 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; MPTP Poisoning; Severity of Illness Index; Time Factors; Treatment Outcome; Video Recording	2017
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset. Psychopharmacology, 2017, Volume: 234, Issue:6 Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Mianserin; Mirtazapine; Motor Activity; MPTP Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced	2017
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model. Pharmacology, biochemistry, and behavior, 2008, Volume: 90, Issue:4 Topics: Animals; Data Interpretation, Statistical; Dopamine Agents; Dyskinesia, Drug-Induced; Jaw; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Tremor; Urea	2008
Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity. Neuroscience letters, 2008, Oct-10, Volume: 443, Issue:3 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Biogenic Monoamines; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Electrochemistry; Hyperkinesis; Levodopa; Mice; Mice, Inbred C57BL; MPTP Poisoning; Olfactory Bulb	2008
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias. Journal of molecular neuroscience : MN, 2009, Volume: 38, Issue:2 Topics: Animals; Autoradiography; Behavior, Animal; Benserazide; Benzoxazoles; Cabergoline; Corpus Striatum; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Ergolines; Female; Humans; Levodopa; Macaca fascicularis; MPTP Poisoning; Ovariectomy; Piperidines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate	2009
The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Oct-15, Volume: 23, Issue:13 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Benzimidazoles; Callithrix; Disability Evaluation; Disease Models, Animal; Drug Synergism; Levodopa; MPTP Poisoning; Nociceptin; Opioid Peptides; Piperidines; Time Factors	2008
Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice. Neuroreport, 2009, Mar-25, Volume: 20, Issue:5 Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agents; Extracellular Space; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neurotoxins; Raclopride; Receptors, Dopamine D2; Tritium	2009
Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model. Brain research, 2009, Mar-25, Volume: 1262 Topics: Animals; Attention; Cognition; Cues; Discrimination Learning; Disease Models, Animal; Dopamine Agents; Drug Combinations; Drug Interactions; Injections, Intramuscular; Injections, Intravenous; Levodopa; Macaca mulatta; Male; Memory; MPTP Poisoning; Nicotine; Nicotinic Agonists; Phenols; Pyrrolidines; Reaction Time; Task Performance and Analysis	2009
Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease. Biological psychiatry, 2009, Sep-15, Volume: 66, Issue:6 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Dyskinesia, Drug-Induced; Female; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Iodine Radioisotopes; Levodopa; Linear Models; Macaca fascicularis; Male; MPTP Poisoning; Nortropanes; Protein Binding; Proto-Oncogene Proteins c-jun; Radionuclide Imaging; RNA, Messenger	2009
Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction. Experimental neurology, 2009, Volume: 219, Issue:2 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Callithrix; Disease Models, Animal; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; Motor Skills; MPTP Poisoning; Tetrahydronaphthalenes; Thiophenes	2009
Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid. Neurobiology of disease, 2009, Volume: 36, Issue:1 Topics: Acetylcholinesterase; Analysis of Variance; Animals; Antiparkinson Agents; Autoradiography; Brain; Cocaine; Disease Models, Animal; Docosahexaenoic Acids; Drug Interactions; Dyskinesia, Drug-Induced; Female; Iodine Isotopes; Levodopa; Macaca fascicularis; MPTP Poisoning; Nuclear Receptor Subfamily 4, Group A, Member 1; Protein Binding; RNA, Messenger; Statistics as Topic	2009
Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets. Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:1 Topics: Animals; Antiparkinson Agents; Brain; Callithrix; Catechol O-Methyltransferase; Cell Membrane; Cerebral Cortex; Corpus Striatum; Dyskinesia, Drug-Induced; Female; Levodopa; Liver; Male; MPTP Poisoning; Neuroglia; Neurons; RNA, Messenger	2010
The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa. Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:1 Topics: Animals; Antiparkinson Agents; Callithrix; Disability Evaluation; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Locomotion; Male; MPTP Poisoning; Receptors, Dopamine D2; Time Factors; Treatment Outcome	2010
Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets. Experimental neurology, 2010, Volume: 221, Issue:1 Topics: Animals; Callithrix; Disability Evaluation; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Statistics, Nonparametric; Tetrahydronaphthalenes; Thiophenes; Time Factors	2010
L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation. Neurochemistry international, 2010, Volume: 56, Issue:2 Topics: Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Electrochemistry; Levodopa; Male; Mice; Mice, Inbred BALB C; MPTP Poisoning; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley	2010
BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys. Movement disorders : official journal of the Movement Disorder Society, 2010, Jan-15, Volume: 25, Issue:1 Topics: Animals; Antiparkinson Agents; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dyskinesia, Drug-Induced; Enzyme-Linked Immunosorbent Assay; Female; Levodopa; Macaca fascicularis; MPTP Poisoning	2010
Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets. Movement disorders : official journal of the Movement Disorder Society, 2010, Feb-15, Volume: 25, Issue:3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Callithrix; Carbidopa; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesias; Levodopa; Male; Motor Activity; MPTP Poisoning; Pramipexole; Time Factors	2010
Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. Journal of neurochemistry, 2010, Volume: 113, Issue:3 Topics: Animals; Antiparkinson Agents; Autoradiography; Biogenic Amines; Brain Chemistry; Catecholamines; Caudate Nucleus; Data Interpretation, Statistical; Dopamine Plasma Membrane Transport Proteins; Female; In Situ Hybridization; Levodopa; Macaca fascicularis; MPTP Poisoning; Ovariectomy; Oximes; Parkinson Disease, Secondary; Putamen; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reserpine; RNA, Messenger	2010
Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:3 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Piperidines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Thiazoles	2010
Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias. Neuroscience, 2010, Jun-02, Volume: 167, Issue:4 Topics: Animals; Antiparkinson Agents; Autoradiography; Benzoxazoles; Brain; Cabergoline; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Female; Imidazoles; Levodopa; Ligands; Macaca fascicularis; MPTP Poisoning; Piperidines; Quinazolines; Receptors, AMPA; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate	2010
Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Jul-30, Volume: 25, Issue:10 Topics: Akathisia, Drug-Induced; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Famotidine; Female; Histamine H2 Antagonists; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Time Factors	2010
5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA. Neurobiology of aging, 2012, Volume: 33, Issue:1 Topics: Animals; Autoradiography; Brain; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; MPTP Poisoning; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Synaptic Transmission	2012
Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 336, Issue:2 Topics: Amides; Amidohydrolases; Animals; Benzamides; Callithrix; Carbamates; Disease Models, Animal; Dyskinesia, Drug-Induced; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Female; Levodopa; Motor Activity; MPTP Poisoning; Oleic Acids; Palmitic Acids; Psychoses, Substance-Induced	2011
Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys. Parkinsonism & related disorders, 2011, Volume: 17, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Carotid Arteries; Conditioning, Operant; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Female; Injections, Intravenous; Levodopa; Macaca mulatta; MPTP Poisoning; Parkinson Disease, Secondary; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Substantia Nigra	2011
A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. Behavioural pharmacology, 2011, Volume: 22, Issue:3 Topics: Animals; Bupropion; Callithrix; Dose-Response Relationship, Drug; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Stereoisomerism	2011
Characterization of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers in vitro and in the MPTP-lesioned primate: R-MDMA reduces severity of dyskinesia, whereas S-MDMA extends duration of ON-time. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, May-11, Volume: 31, Issue:19 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Brain; Callithrix; Dyskinesia, Drug-Induced; Female; Levodopa; Motor Activity; MPTP Poisoning; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stereoisomerism	2011
MPTP-induced models of Parkinson's disease in mice and non-human primates. Current protocols in pharmacology, 2005, Volume: Chapter 5 Topics: Animals; Callithrix; Disease Models, Animal; Dyskinesia, Drug-Induced; Levodopa; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning	2005
Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:13 Topics: Amantadine; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Disease Models, Animal; Dopamine Agonists; Drug Synergism; Dyskinesia, Drug-Induced; Fructose; Levodopa; Male; MPTP Poisoning; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Topiramate	2011
Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia. The European journal of neuroscience, 2011, Volume: 34, Issue:9 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antiparkinson Agents; Basal Ganglia; Biological Clocks; Brain Waves; Disease Models, Animal; Dopamine; Electric Stimulation; Functional Laterality; Globus Pallidus; Levodopa; Macaca; Male; MPTP Poisoning; Neurons; Statistics, Nonparametric; Subthalamic Nucleus	2011
Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against Parkinson's disease in the MPTP-induced mice model. Journal of drug targeting, 2012, Volume: 20, Issue:1 Topics: Animals; Cells, Cultured; Disease Models, Animal; Drug Delivery Systems; Levodopa; Liposomes; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease; Random Allocation; Scorpion Venoms	2012
Behavioral improvement in MPTP-treated nonhuman primates in the HALLWAY task after transfer of TH cDNA to host astrocytes. Acta neurobiologiae experimentalis, 2012, Volume: 72, Issue:2 Topics: Animals; Astrocytes; Behavior, Animal; Chlorocebus aethiops; DNA, Complementary; Dopamine Agents; Gene Transfer Techniques; Genetic Vectors; Glial Fibrillary Acidic Protein; Humans; Levodopa; Magnetic Resonance Imaging; Male; MPTP Poisoning; Neostriatum; Psychomotor Performance; Tyrosine 3-Monooxygenase	2012
Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function. Neurobiology of disease, 2013, Volume: 50 Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Male; MPTP Poisoning; Nicotine; Nicotinic Agonists; Presynaptic Terminals; Receptors, Nicotinic; Saimiri	2013
Preclinical models of Parkinson's disease. Current protocols in toxicology, 2004, Volume: Chapter 1 Topics: Animals; Disease Models, Animal; Levodopa; Macaca fascicularis; Macaca mulatta; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Parkinson Disease; Rats; Rats, Sprague-Dawley	2004
Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy. Journal of neurosurgery, 2013, Volume: 118, Issue:1 Topics: Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Ibotenic Acid; Levodopa; Macaca fascicularis; MPTP Poisoning; Subthalamic Nucleus	2013
Physical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner. BMC neuroscience, 2012, Oct-31, Volume: 13 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adult Stem Cells; Analysis of Variance; Animals; Antigens; Bromodeoxyuridine; Calcium-Binding Proteins; Cells, Cultured; Disease Models, Animal; Dopamine; Dopamine Agents; Environment; Female; Green Fluorescent Proteins; Intermediate Filament Proteins; Levodopa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Nestin; Proteoglycans; Substantia Nigra; Tyrosine 3-Monooxygenase	2012
Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; Cognition Disorders; Conditioning, Operant; Disease Models, Animal; Levodopa; Macaca fascicularis; Male; Movement; MPTP Poisoning; Photic Stimulation; Time Factors	2013
Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque. The European journal of neuroscience, 2013, Volume: 37, Issue:5 Topics: Animals; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Nitriles	2013
The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques. Progress in neuro-psychopharmacology & biological psychiatry, 2013, Jun-03, Volume: 43 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Butyrophenones; Cloning, Molecular; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Psychoses, Substance-Induced	2013
What helps can also hinder: a dissociation in the acute effect of levodopa treatment on motor and cognitive functions. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:5 Topics: Animals; Antiparkinson Agents; Cognition Disorders; Levodopa; Male; Movement; MPTP Poisoning	2013
Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration. Behavioural brain research, 2003, Feb-17, Volume: 139, Issue:1-2 Topics: Animals; Behavior, Animal; Brain Chemistry; Critical Period, Psychological; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Habituation, Psychophysiologic; Iron; Iron Overload; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Time	2003
Rest tremor in rhesus monkeys with MPTP-induced parkinsonism. Frontiers in bioscience : a journal and virtual library, 2003, May-01, Volume: 8 Topics: Animals; Female; Levodopa; Macaca mulatta; Male; MPTP Poisoning; Parkinson Disease, Secondary; Tremor	2003
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nature medicine, 2003, Volume: 9, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acrylamides; Animals; Antiparkinson Agents; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Haplorhini; Humans; Isoquinolines; Levodopa; Molecular Structure; Motor Activity; MPTP Poisoning; Naphthalenes; Neostriatum; Piperazines; Pyrrolidines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3	2003
L-DOPA treatment modulates nicotinic receptors in monkey striatum. Molecular pharmacology, 2003, Volume: 64, Issue:3 Topics: Animals; Corpus Striatum; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Levodopa; Male; MPTP Poisoning; Protein Binding; Receptors, Nicotinic; Saimiri	2003
Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:12 Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Dopamine; Homovanillic Acid; Immunohistochemistry; Levodopa; Male; Mice; MPTP Poisoning; Neuropeptide Y; Neuroprotective Agents; Selegiline; Serotonin	2003
Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque. European journal of pharmacology, 2004, Feb-06, Volume: 485, Issue:1-3 Topics: Animals; Chorea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levetiracetam; Levodopa; Macaca fascicularis; MPTP Poisoning; Piracetam	2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3 Topics: Acetylcholine; Animals; Callithrix; Cells, Cultured; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Dyskinesias; Electrophysiology; Extracellular Space; Humans; Hypokinesia; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Rotation	2004
Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:1 Topics: Amantadine; Animals; Anticonvulsants; Antiparkinson Agents; Callithrix; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesias; Female; Levetiracetam; Levodopa; Male; MPTP Poisoning; Piracetam	2004
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Interactions; Levodopa; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nervous System Diseases; Nitrophenols; Oxazoles; Oxidopamine; Prefrontal Cortex; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Tolcapone; Tremor; Tyramine	2004
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Callithrix; Carbidopa; Catechols; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Injections, Subcutaneous; Levodopa; Locomotion; Male; MPTP Poisoning; Nitriles; Severity of Illness Index; Substantia Nigra; Time Factors	2005
Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:4 Topics: Animals; Anticonvulsants; Antiparkinson Agents; Callithrix; Disease Models, Animal; Dyskinesia, Drug-Induced; Fructose; Levodopa; MPTP Poisoning; Parkinson Disease; Topiramate	2005
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:9 Topics: Animals; Arachidonic Acids; Callithrix; Cannabinoid Receptor Modulators; Dyskinesia, Drug-Induced; Endocannabinoids; Female; gamma-Aminobutyric Acid; Glycerides; Levodopa; Male; MPTP Poisoning; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2005
The effects of a selective dopamine D2 receptor agonist on behavioral and pathological outcome in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated squirrel monkeys. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:3 Topics: Animals; Basal Ganglia; Benzimidazoles; Biogenic Monoamines; Dopamine Agonists; Levodopa; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D2; Saimiri; Substantia Nigra	2005
In vivo models of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20 Suppl 12 Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Corpus Striatum; Levodopa; Macaca fascicularis; Mice; MPTP Poisoning; Multiple System Atrophy; Oxidopamine; Parkinsonian Disorders; Point Mutation; Rats; Substantia Nigra	2005
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys. Experimental neurology, 2006, Volume: 197, Issue:2 Topics: Animals; Antiparkinson Agents; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal; Corpus Striatum; Dependovirus; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gene Transfer Techniques; Immunohistochemistry; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; MPTP Poisoning; Neurons; Parkinson Disease, Secondary; Positron-Emission Tomography; Time Factors	2006
Influence of noradrenaline denervation on MPTP-induced deficits in mice. Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:9 Topics: Animals; Auditory Pathways; Behavior, Animal; Benzylamines; Brain Chemistry; Denervation; Dopamine Agents; Hippocampus; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neostriatum; Norepinephrine; Prefrontal Cortex; Substantia Nigra	2006
Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Annals of neurology, 2006, Volume: 59, Issue:2 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Female; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Ovariectomy; Severity of Illness Index; Time Factors	2006
Pedunculopontine nucleus electric stimulation alleviates akinesia independently of dopaminergic mechanisms. Neuroreport, 2006, Apr-24, Volume: 17, Issue:6 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Dopamine; Dose-Response Relationship, Radiation; Electric Stimulation; Levodopa; Macaca mulatta; Male; Motor Activity; MPTP Poisoning; Pedunculopontine Tegmental Nucleus	2006
The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets. European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3 Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Callithrix; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; Motor Skills; MPTP Poisoning; Triazoles	2006
Postnatal iron overload destroys NA-DA functional interactions. Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:2 Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Benzylamines; Clonidine; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Iron Overload; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Norepinephrine	2007
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:12 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Indoles; Levodopa; Motor Activity; MPTP Poisoning; Oxazines; Piperidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Time Factors	2006
The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochemistry international, 2007, Volume: 50, Issue:6 Topics: Animals; Blotting, Western; Cyclic GMP; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Electrophoresis, Polyacrylamide Gel; Guanylate Cyclase; Immunohistochemistry; Levodopa; Mesencephalon; Mice; Mice, Inbred C57BL; Microdialysis; MPTP Poisoning; Neostriatum; Nerve Degeneration; Nerve Tissue Proteins; Nitric Oxide Synthase Type I; Phosphoric Diester Hydrolases; RNA, Messenger; Synaptosomes	2007
L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates. Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:9 Topics: Animals; Callithrix; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Severity of Illness Index	2007
Striatal leucine-rich repeat kinase 2 mRNA is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned common marmosets (Callithrix jacchus) with L-3, 4-dihydroxyphenylalanine methyl ester-induced dyskinesia. The European journal of neuroscience, 2007, Volume: 26, Issue:1 Topics: Actins; Aged; Aged, 80 and over; Animals; Antiparkinson Agents; Callithrix; Data Interpretation, Statistical; Dopamine Agents; Dyskinesia, Drug-Induced; Electrophoresis, Polyacrylamide Gel; Female; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Male; Middle Aged; MPTP Poisoning; Neostriatum; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra	2007
Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor. Neurochemical research, 2007, Volume: 32, Issue:10 Topics: Animals; Animals, Newborn; Antipsychotic Agents; Brain Chemistry; Catecholamines; Clozapine; Denervation; Dopamine; Dopamine Agents; Female; Haloperidol; Iron; Iron Overload; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Movement Disorders; MPTP Poisoning; Norepinephrine; Pregnancy; Psychotic Disorders; Signal Transduction; Weight Gain	2007
Preclinical models of Parkinson's disease. Current protocols in neuroscience, 2001, Volume: Chapter 9 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Injections, Intra-Arterial; Injections, Intravenous; Levodopa; Macaca fascicularis; Macaca mulatta; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Primates; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Species Specificity	2001
Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience, 1993, Volume: 55, Issue:1 Topics: Afferent Pathways; Animals; Apomorphine; Axonal Transport; Brain Mapping; Chorea; Dyskinesia, Drug-Induced; Dystonia; Globus Pallidus; Horseradish Peroxidase; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Stereotaxic Techniques; Thalamus; Wheat Germ Agglutinins	1993
Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment. European journal of pharmacology, 1994, Oct-24, Volume: 264, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; Azepines; Callithrix; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Levodopa; Male; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary	1994
Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1 Topics: Animals; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2	1993
Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism. Brain research, 1993, Feb-05, Volume: 602, Issue:2 Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Caudate Nucleus; Dopamine Agents; Female; Infusions, Intravenous; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride	1993
Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Journal of neurochemistry, 1994, Volume: 62, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Drug Implants; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; MPTP Poisoning; Neurotoxins; Orchiectomy; Parkinson Disease, Secondary; Reference Values; Species Specificity; Testosterone	1994
Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience, 1995, Volume: 68, Issue:4 Topics: Animals; Antiparkinson Agents; Caudate Nucleus; Dopamine Agents; Enkephalins; Gene Expression; In Situ Hybridization; Levodopa; Macaca fascicularis; MPTP Poisoning; Neostriatum; Oligonucleotides, Antisense; Parkinson Disease, Secondary; Protein Precursors; Putamen; RNA, Messenger; Tachykinins	1995
Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. Journal of neurochemistry, 1996, Volume: 66, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Estradiol; Female; Levodopa; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; MPTP Poisoning; Osmolar Concentration; Ovariectomy	1996
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study. Neuroscience, 1996, Volume: 71, Issue:4 Topics: Aged; Aged, 80 and over; Animals; Basal Ganglia; Densitometry; Electron Transport Complex IV; Female; Histocytochemistry; Humans; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease; Parkinson Disease, Secondary	1996
Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. Brain research. Molecular brain research, 1996, Volume: 42, Issue:1 Topics: Animals; Cell Count; Cell Size; Corpus Striatum; Dopamine Agents; Levodopa; Macaca fascicularis; MPTP Poisoning; Neurons; Parkinson Disease, Secondary; Receptors, Dopamine D2; RNA, Messenger	1996
Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997, Jan-15, Volume: 17, Issue:2 Topics: Aged; Aged, 80 and over; Animals; Basal Ganglia; Corpus Striatum; Denervation; Electron Transport Complex IV; Enzyme Induction; Female; Globus Pallidus; Humans; In Situ Hybridization; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; RNA, Messenger; Substantia Nigra	1997
[The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome]. Biulleten' eksperimental'noi biologii i meditsiny, 1996, Volume: 122, Issue:12 Topics: Animals; Blood-Brain Barrier; Corpus Striatum; Dopamine; Dopamine Agents; Levodopa; Liposomes; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease, Secondary; Phospholipids	1996
Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2 Topics: Animals; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3	1997
Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain research, 1998, Mar-16, Volume: 787, Issue:1 Topics: Animals; Dopamine Agents; Female; Globus Pallidus; Immunohistochemistry; Levodopa; Macaca mulatta; MPTP Poisoning; Neurons; Parkinson Disease, Secondary	1998
MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose. Experimental neurology, 1998, Volume: 152, Issue:2 Topics: Animals; Antiparkinson Agents; Carotid Arteries; Dopamine Agents; Drug Administration Schedule; Female; Follow-Up Studies; Infusions, Intra-Arterial; Levodopa; Macaca nemestrina; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Rotation	1998
Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys. Experimental neurology, 1998, Volume: 152, Issue:2 Topics: Animals; Antiparkinson Agents; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Levodopa; Macaca nemestrina; MPTP Poisoning; Parkinson Disease, Secondary; Treatment Outcome; Trihexyphenidyl	1998
Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:3 Topics: Animals; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Oocytes; Parkinson Disease, Secondary; Rats; Receptors, N-Methyl-D-Aspartate; Valine; Xenopus laevis	1999
Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology, 1999, Volume: 146, Issue:3 Topics: Animals; Antiparkinson Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Levodopa; Macaca mulatta; Male; MPTP Poisoning; Parkinson Disease; Receptors, Dopamine D1	1999
Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys. Psychopharmacology, 1999, Volume: 147, Issue:1 Topics: Animals; Antiparkinson Agents; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Levodopa; Macaca mulatta; Male; Memory; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Psychomotor Performance; Space Perception	1999
Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys. Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:2 Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Idazoxan; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Norepinephrine; Parkinson Disease	2000
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. Journal of neuroscience methods, 2000, Mar-01, Volume: 96, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Neurologic Examination; Severity of Illness Index	2000
The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958. Behavioural pharmacology, 1999, Volume: 10, Issue:2 Topics: Animals; Antiparkinson Agents; Arm; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography; Epilepsy; Levodopa; Macaca mulatta; Male; Motor Activity; Movement; MPTP Poisoning; Parkinson Disease, Secondary; Predictive Value of Tests; Receptors, Dopamine D1	1999
Effects of ropinirole on motor behavior in MPTP-treated common marmosets. Pharmacology, biochemistry, and behavior, 2000, Volume: 67, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Agonists; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D2; Receptors, Dopamine D3	2000
GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets. The European journal of neuroscience, 2001, Volume: 13, Issue:3 Topics: Animals; Antiparkinson Agents; Body Weight; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Gene Expression; Glial Cell Line-Derived Neurotrophic Factor; Levodopa; Locomotion; Male; Mazindol; MPTP Poisoning; Nerve Growth Factors; Nerve Tissue Proteins; Neuroprotective Agents; Protein Precursors; Recovery of Function; RNA, Messenger; Substantia Nigra; Tachykinins; Tritium; Tyrosine 3-Monooxygenase	2001
Emerging perspectives in Parkinson's disease. Neurology, 1992, Volume: 42, Issue:4 Suppl 4 Topics: Animals; Humans; Levodopa; MPTP Poisoning; Neurology; Parkinson Disease; Parkinson Disease, Secondary; Selegiline	1992
The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys. Annals of neurology, 1991, Volume: 30, Issue:5 Topics: Animals; Dopamine; Female; Globus Pallidus; Levodopa; Macaca mulatta; MPTP Poisoning; Parkinson Disease, Secondary; Quinoxalines; Rats; Receptors, AMPA; Receptors, Neurotransmitter; Synaptic Transmission	1991
Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 259, Issue:1 Topics: Animals; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary	1991
Alterations of somatostatin and its modulation by levodopa in MPTP-treated mouse brain. Journal of the neurological sciences, 1990, Volume: 100, Issue:1-2 Topics: Animals; Brain Chemistry; Dopamine; Levodopa; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Norepinephrine; Sincalide; Somatostatin; Substance P; Thyrotropin-Releasing Hormone	1990
Modulatory role for CCK-B antagonists in Parkinson's disease. Clinical neuropharmacology, 1990, Volume: 13, Issue:4 Topics: Animals; Benzodiazepinones; Carbidopa; Cholecystokinin; Devazepide; Dopamine Agents; Levodopa; Male; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenylurea Compounds; Receptors, Cholecystokinin; Saimiri	1990
Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. Journal of neural transmission. Parkinson's disease and dementia section, 1991, Volume: 3, Issue:1 Topics: Acetylcarnitine; Animals; Carbidopa; Caudate Nucleus; Electroretinography; Female; Homovanillic Acid; Immunohistochemistry; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Substantia Nigra	1991
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393. European journal of pharmacology, 1990, Aug-28, Volume: 185, Issue:2-3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone	1990
Induction of chorea and dystonia in parkinsonian primates. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:1 Topics: Animals; Chorea; Dystonia; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary	1990
Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey. Neuropharmacology, 1989, Volume: 28, Issue:11 Topics: Animals; Aspartic Acid; Dibenzocycloheptenes; Dizocilpine Maleate; Injections, Intramuscular; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; N-Methylaspartate; Parkinson Disease, Secondary	1989